<DOC>
	<DOCNO>NCT00051207</DOCNO>
	<brief_summary>This 6-month study , 3-month follow period , compare effectiveness new traditional psychotherapy depression panic anxiety symptom .</brief_summary>
	<brief_title>Therapy Depression With Co-occurring Panic Anxiety Symptoms</brief_title>
	<detailed_description>Many depress patient also experience significant symptom panic anxiety . This study compare effectiveness new therapy call interpersonal psychotherapy depression panic anxiety symptom ( IPT-PS ) traditional interpersonal psychotherapy depression ( IPT ) . Participants randomly assign receive 24 week treatment either IPT-PS traditional IPT . Improvements interpersonal functioning , quality life , symptom depression anxiety assessed end therapy 3-month follow-up .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Panic Disorder</mesh_term>
	<criteria>DSMIV diagnosis major depression coexist panic anxiety symptom . History manic episode ( ) . Patients hypomanic episode past accepted study , provide meet admission criterion present current hypomanic mixed episode . History schizophrenia schizoaffective disorder . Organic affective syndrome . Unspecified functional psychosis . Anorexia nervosa bulimia nervosa . Patients meet criterion eat disorder otherwise specify exclude . Chronic drug alcohol abuse/dependence within past 2 year . Patients abuse related episode exclude . DSMIV criterion borderline antisocial personality disorder . Patients meet criterion Axis II disorder exclude . Inpatient treatment due suicide risk psychotic symptom . Index episode secondary effect medically prescribe drug . Significant untreated medical illness , include cardiovascular disorder , renal liver disease , epilepsy , untreated hypertension , unstabilized endocrine disease . Medical illness would interfere best treatment strategy potential participant . Current treatment antidepressant . Patients stable dose anxiolytic least 3 month prior study participation able maintain dosage throughout study exclude . Pregnant breastfeed woman accept study , prescribe adjunctive medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Mood Disorders</keyword>
	<keyword>Psychotherapy</keyword>
	<keyword>Comorbidity</keyword>
</DOC>